Search research articles
Contact Us
Filters
Showing results (141-150 of 246) with videos related to
Page
of 25
Sort By:
Journal of Analytical Toxicology
|
August 18, 2005
Papain: a novel urine adulterant
David L Burrows, Andrea Nicolaides, Peter J Rice, et al.
Advances in Therapy
|
September 27, 2018
Pilot, Randomized, Blinded, Placebo-Controlled Trial Investigating the Correlation Between Acid Control and Heartburn Relief with 14 Days of Esomeprazole Treatment
Philip B Miner, David A Johnson, Philip O Katz, et al.
Heliyon
|
April 27, 2023
The gut microbiome-Does stool represent right?
Orly Levitan, Lanying Ma, Donato Giovannelli, et al.
World Journal of Gastroenterology
|
May 24, 2021
Role of microbial dysbiosis in the pathogenesis of esophageal mucosal disease: A paradigm shift from acid to bacteria?
Steve M D'Souza, Kevin Houston, Lauren Keenan, et al.
The Western Journal of Emergency Medicine
|
August 13, 2015
Prehospital Evaluation of Effusion, Pneumothorax, and Standstill (PEEPS): Point-of-care Ultrasound in Emergency Medical Services
Sundeep R Bhat, David A Johnson, Jessica E Pierog, et al.
Plos One
|
June 6, 2014
Plasma Septin9 versus fecal immunochemical testing for colorectal cancer screening: a prospective multicenter study
David A Johnson, Robert L Barclay, Klaus Mergener, et al.
Journal of Clinical Gastroenterology
|
August 23, 2011
The financial impact of outpatient gastroenterology patient phone calls: an activity-based cost analysis
Raj Majithia, David A Johnson, Michael J Ryan, et al.
Gastroenterology
|
July 6, 2012
Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer
David A Lieberman, Douglas K Rex, Sidney J Winawer, et al.
Expert Review of Vaccines
|
August 6, 2003
Enhancement of antigen-specific immunity via the TLR4 ligands MPL adjuvant and Ribi.529
Jay T Evans, Christopher W Cluff, David A Johnson, et al.
Science Signaling
|
February 17, 2012
Selective TRIF-dependent signaling by a synthetic toll-like receptor 4 agonist
William S Bowen, Laurie A Minns, David A Johnson, et al.
Page
of 25
Search research articles
Search
Showing results (141-150 of 246) with videos related to
Sort By:
Page
of 25
Journal of Analytical Toxicology
|
August 18, 2005
Papain: a novel urine adulterant
David L Burrows, Andrea Nicolaides, Peter J Rice, et al.
Advances in Therapy
|
September 27, 2018
Pilot, Randomized, Blinded, Placebo-Controlled Trial Investigating the Correlation Between Acid Control and Heartburn Relief with 14 Days of Esomeprazole Treatment
Philip B Miner, David A Johnson, Philip O Katz, et al.
Heliyon
|
April 27, 2023
The gut microbiome-Does stool represent right?
Orly Levitan, Lanying Ma, Donato Giovannelli, et al.
World Journal of Gastroenterology
|
May 24, 2021
Role of microbial dysbiosis in the pathogenesis of esophageal mucosal disease: A paradigm shift from acid to bacteria?
Steve M D'Souza, Kevin Houston, Lauren Keenan, et al.
The Western Journal of Emergency Medicine
|
August 13, 2015
Prehospital Evaluation of Effusion, Pneumothorax, and Standstill (PEEPS): Point-of-care Ultrasound in Emergency Medical Services
Sundeep R Bhat, David A Johnson, Jessica E Pierog, et al.
Plos One
|
June 6, 2014
Plasma Septin9 versus fecal immunochemical testing for colorectal cancer screening: a prospective multicenter study
David A Johnson, Robert L Barclay, Klaus Mergener, et al.
Journal of Clinical Gastroenterology
|
August 23, 2011
The financial impact of outpatient gastroenterology patient phone calls: an activity-based cost analysis
Raj Majithia, David A Johnson, Michael J Ryan, et al.
Gastroenterology
|
July 6, 2012
Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer
David A Lieberman, Douglas K Rex, Sidney J Winawer, et al.
Expert Review of Vaccines
|
August 6, 2003
Enhancement of antigen-specific immunity via the TLR4 ligands MPL adjuvant and Ribi.529
Jay T Evans, Christopher W Cluff, David A Johnson, et al.
Science Signaling
|
February 17, 2012
Selective TRIF-dependent signaling by a synthetic toll-like receptor 4 agonist
William S Bowen, Laurie A Minns, David A Johnson, et al.
Page
of 25